Malcolm Lloyd-smith - Net Worth and Insider Trading
Malcolm Lloyd-smith Net Worth
The estimated net worth of Malcolm Lloyd-smith is at least $5 Million dollars as of 2024-09-24. Malcolm Lloyd-smith is the Chief Integration Officer of Neurocrine Biosciences Inc and owns about 42,337 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $5 Million. Details can be seen in Malcolm Lloyd-smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Malcolm Lloyd-smith has not made any transactions after 2023-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Malcolm Lloyd-smith
Malcolm Lloyd-smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Malcolm Lloyd-smith owns 1 companies in total, including Neurocrine Biosciences Inc (NBIX) .
Click here to see the complete history of Malcolm Lloyd-smith’s form 4 insider trades.
Insider Ownership Summary of Malcolm Lloyd-smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2023-02-08 | Chief Regulatory Officer |
Malcolm Lloyd-smith Latest Holdings Summary
Malcolm Lloyd-smith currently owns a total of 1 stock. Malcolm Lloyd-smith owns 42,337 shares of Neurocrine Biosciences Inc (NBIX) as of February 8, 2023, with a value of $5 Million.
Latest Holdings of Malcolm Lloyd-smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2023-02-08 | 42,337 | 116.49 | 4,931,837 |
Holding Weightings of Malcolm Lloyd-smith
Malcolm Lloyd-smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Malcolm Lloyd-smith has made a total of 14 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 15,318 shares on February 8, 2023, which brought Malcolm Lloyd-smith around $2 Million.
Insider Trading History of Malcolm Lloyd-smith
- 1
Malcolm Lloyd-smith Trading Performance
Malcolm Lloyd-smith Ownership Network
Malcolm Lloyd-smith Owned Company Details
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Malcolm Lloyd-smith is the Chief Regulatory Officer of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Corp. Affairs Officer David W. Boyer , Chief Regulatory Officer Ingrid Delaet , and Chief Financial Officer Matt Abernethy .
Neurocrine Biosciences Inc (NBIX) Insider Trades Summary
Over the past 18 months, Malcolm Lloyd-smith made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 32,776 shares made by Ingrid Delaet , a net sale of 67,065 shares made by Julie Cooke , and a net sale of 132,270 shares made by Eiry Roberts .
In summary, during the past 3 months, insiders sold 89,288 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 89,288 shares. During the past 18 months, 1,029,798 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,029,798 shares.
Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
Malcolm Lloyd-smith Mailing Address
Above is the net worth, insider trading, and ownership report for Malcolm Lloyd-smith. You might contact Malcolm Lloyd-smith via mailing address: 12481 High Bluff Drive, Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
